At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Jun 3, 2026 at 16:54 ET
Seven NovoCure directors sold identical blocks of 2,945 shares each at $15.77 on June 2, 2026, totaling $325K in open-market sales. The uniform size and timing strongly suggest a coordinated sale, likely tied to a pre-arranged plan or tax-related event rather than opportunistic bearish conviction. Two directors also received non-cash stock grants on June 3, further supporting a routine compensation/planning context. At $2.1B market cap, the $325K represents just 0.015% of market cap, well below the 0.1% materiality threshold.
- Seven directors each sold exactly 2,945 shares at $15.7707 on June 2, 2026, identical size and price point across all sellers
- Total open-market sale value: $325,112.98 (0.015% of $2.1B market cap)
- Two directors (Vernon W. Anthony and Martin J. Madden) received non-cash stock grants totaling 28,609 shares on June 3, 2026
- No C-suite executives (CEO, CFO, COO) participated in the sales, only board members
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access